British Pharmaceutical company ‘Shire’ enters into domestic market

On May 27, according to the related industry, Shire Pharmaceutical which is specialized in rare disorder, confirmed entry into the country, and finished recruitment of overseas presidents in Korea.

Shire is known for the development company of 'Elaprase' which is for Hunter syndrome treatment, and equipped with a competitiveness in the field of psychiatry. In particular, it is the world market...